ECGI Holdings Inc (ECGI)

[Potse]

Diagnostic yields...significant improvements.....

I'm still anticipating that SUIP will see significantly higher share prices within the next 6-12 months or so (either in the form of a somewhat sustained move higher, or tradeable spikes). That is obviously to a large degree contingent on what things look like from any financing/debt/etc standpoint.

It appears that John Bentivoglio has hired Porter, LeVay & Rose to handle investor relations for SUIP (Event Cardio Group). IMO, that is an encouraging development.

The expected diagnostic yield numbers of Event Cardio Group's medical device could represent a significant performance improvement over current devices/technology. Nicholas Bozza appears to be pretty well-connected in the cardiac area of the medical industry, so if Now Cardio achieves the kind of performance numbers they are expecting, the product and SUIP are probably going to get a few eyebrows to raise.

From today's press release.....

Under the current state of technology, cardiac monitoring suffers from patients failing to wear their monitoring devices. The diagnostic yield from the data collected from holter monitors is as low as 4% and from event recorders 62%.

ECG is developing a new product, Now Cardio™, an advanced cardiac monitor which offers dual-functionality including both holter monitoring and event recording simultaneously. As a wireless and leadless system, it is more comfortable to wear, and as a result, is more likely to be worn. Based on experience, ECG believes it can reach diagnostic yields greater than 90%. ECG believes that this would be a meaningful first within the industry.